Search

everythinglearnresearchcommunity

for

Search:↓

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Erlotinib can cause persistent excessive hair growth.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Glycerin in hand cream can cause allergic skin reactions.

Primary care providers should understand Geschlechtsinkongruenz to offer better care for transitioning individuals.

Self-induced vomiting in anorexia can lead to rare gout complications.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

A woman with anorexia developed gout from self-induced vomiting.

A girl had rickets due to a gene mutation affecting vitamin D response.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Alopecia patients have less GPER-1, which might affect hair loss.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Most genital symptoms in prepubertal girls are normal or nontraumatic, not signs of abuse.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

A rare EGFR mutation in newborns leads to severe health issues and early death.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.